Therapeutic strategies for uncomplicated cystitis in women.
Acute Cystitis Symptom Score
antibiotic resistance
antibiotic therapy
cystitis
diagnosis
non-antibiotic therapy
prophylaxis
urinary tract infection
Journal
GMS infectious diseases
ISSN: 2195-8831
Titre abrégé: GMS Infect Dis
Pays: Germany
ID NLM: 101694381
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
20
5
2024
pubmed:
20
5
2024
entrez:
20
5
2024
Statut:
epublish
Résumé
Uncomplicated cystitis is affecting many women of all ages and has a great impact on the quality of life, especially in women suffering from recurrent, uncomplicated cystitis. By far the most frequent uropathogen,
Identifiants
pubmed: 38764941
doi: 10.3205/id000086
pii: id000086
pmc: PMC11099625
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
Doc01Informations de copyright
Copyright © 2024 Naber et al.
Déclaration de conflit d'intérêts
KGN, JA, AP, and FMW are authors and copyright holders of the ACSS questionnaire. KGN is a consultant of Adamed Pharma, Bionorica, BioMerieux, GlaxoSmithKline, Immunotek, Ingenion Medical, Janssen Pharmaceutica, OM Pharma, and MIP Pharma. JA is an employee of Bionorica SE. WLS is a consultant of Bionorica, Desitin, MIP Pharma. JK is a consultant of Bionorica and GSK. FMW is a consultant of Achaogen, Astellas, AstraZeneca, Bionorica, MSD, Eumedica, GSK, Janssen, Klosterfrau, MIP Pharma, Pfizer, OM Pharma, Qiagen, VenatoRx. RF declares no conflict of interest.